BRCA1 participates in DNA decatenation - PubMed (original) (raw)

Comparative Study

doi: 10.1038/nsmb953. Epub 2005 Jun 19.

Affiliations

• PMID: 15965487
• DOI: 10.1038/nsmb953

Comparative Study

BRCA1 participates in DNA decatenation

Zhenkun Lou et al. Nat Struct Mol Biol. 2005 Jul.

Abstract

The tumor suppressor BRCA1 has an important function in the maintenance of genomic stability. Increasing evidence suggests that BRCA1 regulates cell cycle checkpoints and DNA repair after DNA damage. However, little is known about its normal function in the absence of DNA damage. Here we show that BRCA1 interacts and colocalizes with topoisomerase IIalpha in S phase cells. Similar to cells treated with the topoisomerase IIalpha inhibitor ICRF-193, BRCA1-deficient cells show lagging chromosomes, indicating a defect in DNA decatenation and chromosome segregation. More directly, BRCA1 deficiency results in defective DNA decatenation in vitro. Finally, topoisomerase IIalpha is ubiquitinated in a BRCA1-dependent manner, and topoisomerase IIalpha ubiquitination correlates with higher DNA decatenation activity. Together these results suggest an important role of BRCA1 in DNA decatenation and reveal a previously unknown function of BRCA1 in the maintenance of genomic stability.

PubMed Disclaimer

Similar articles

• Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
  Sakaguchi A, Kikuchi A. Sakaguchi A, et al. J Cell Sci. 2004 Mar 1;117(Pt 7):1047-54. doi: 10.1242/jcs.00977. J Cell Sci. 2004. PMID: 14996935
• Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination.
  Kronenwett U, Castro J, Roblick UJ, Fujioka K, Ostring C, Faridmoghaddam F, Laytragoon-Lewin N, Tribukait B, Auer G. Kronenwett U, et al. BMC Cell Biol. 2003 Jul 22;4:8. doi: 10.1186/1471-2121-4-8. BMC Cell Biol. 2003. PMID: 12875657 Free PMC article.
• Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers.
  Miyoshi Y, Kurosumi M, Kurebayashi J, Matsuura N, Takahashi M, Tokunaga E, Egawa C, Masuda N, Kim SJ, Okishiro M, Yanagisawa T, Ueda S, Taguchi T, Tamaki Y, Noguchi S; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Miyoshi Y, et al. Cancer Lett. 2008 Jun 8;264(1):44-53. doi: 10.1016/j.canlet.2008.01.015. Epub 2008 Feb 15. Cancer Lett. 2008. PMID: 18280644
• The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
  Zhang J, Powell SN. Zhang J, et al. Mol Cancer Res. 2005 Oct;3(10):531-9. doi: 10.1158/1541-7786.MCR-05-0192. Mol Cancer Res. 2005. PMID: 16254187 Review.
• Oh what a tangled web it weaves: BRCA1 and DNA decatenation.
  Ashworth A. Ashworth A. Cancer Cell. 2005 Aug;8(2):95-7. doi: 10.1016/j.ccr.2005.07.011. Cancer Cell. 2005. PMID: 16098462 Review.

Cited by

• Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications.
  Soliman TN, Keifenheim D, Parker PJ, Clarke DJ. Soliman TN, et al. J Cell Biol. 2023 Dec 4;222(12):e202209125. doi: 10.1083/jcb.202209125. Epub 2023 Nov 13. J Cell Biol. 2023. PMID: 37955972 Free PMC article. Review.
• TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells.
  Jaiswal AS, Dutta A, Srinivasan G, Yuan Y, Zhou D, Shaheen M, Sadideen DT, Kirby A, Williamson EA, Gupta YK, Olsen SK, Xu M, Loranc E, Mukhopadhyay P, Pertsemlidis A, Bishop AJR, Sung P, Nickoloff JA, Hromas R. Jaiswal AS, et al. Nucleic Acids Res. 2023 Dec 11;51(22):12224-12241. doi: 10.1093/nar/gkad952. Nucleic Acids Res. 2023. PMID: 37953292 Free PMC article.
• GINS1 promotes the proliferation and migration of glioma cells through USP15-mediated deubiquitination of TOP2A.
  Yang H, Liu X, Zhu X, Zhang M, Wang Y, Ma M, Lv K. Yang H, et al. iScience. 2022 Aug 17;25(9):104952. doi: 10.1016/j.isci.2022.104952. eCollection 2022 Sep 16. iScience. 2022. PMID: 36065190 Free PMC article.
• Genome-Protective Topoisomerase 2a-Dependent G2 Arrest Requires p53 in hTERT-Positive Cancer Cells.
  Lockwood N, Martini S, Lopez-Pardo A, Deiss K, Segeren HA, Semple RK, Collins I, Repana D, Cobbaut M, Soliman T, Ciccarelli F, Parker PJ. Lockwood N, et al. Cancer Res. 2022 May 3;82(9):1762-1773. doi: 10.1158/0008-5472.CAN-21-1785. Cancer Res. 2022. PMID: 35247890 Free PMC article.
• BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ.
  Bunch H, Jeong J, Kang K, Jo DS, Cong ATQ, Kim D, Kim D, Cho DH, Lee YM, Chen BPC, Schellenberg MJ, Calderwood SK. Bunch H, et al. Open Biol. 2021 Oct;11(10):210221. doi: 10.1098/rsob.210221. Epub 2021 Oct 6. Open Biol. 2021. PMID: 34610268 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • IMEx Consortium

• Miscellaneous

  • NCI CPTAC Assay Portal